訊飛醫療2024年“成績單”:營收達7.3億元同比增長32%,成長性再獲驗證
今日盤後,訊飛醫療(2506.HK)發佈2024年度業績公告。報告顯示,公司全年實現營業收入7.34億元,同比增長32.0%,增速較過去一年穩步提升;實現毛利4.04億元,同比增長28.4%。公司G端業務企穩,收入同比增長10%,達到3.91億元。患者服務、醫院服務以及區域管理平臺解決方案的業務增長對整體利潤貢獻持續增加。其中,醫院服務業務收入同比增長103.4%,智慧醫院解決方案已覆蓋全國500餘家等級醫院,包括40餘家百強醫院和7家全國十強醫院;患者服務收入同比增長56.6%,C端市場領先地位進一步鞏固;區域管理平臺解決方案收入同比增長31.8%,在安徽、河南等省級公共衛生平臺建設中發揮關鍵作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.